{"transactions":[{"id":3570217,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-02T20:02:00.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":6854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.3333% of the shares subject to the option shall vest on March 13, 2020, with the remainder vesting in equal monthly installments of 2.7777% of the shares subject to the option until the 36-month anniversary of the date of the award, subject to the Reporting Person continuing to provide service through each such date. This amendment is being filed solely to report this additional stock option grant, which was granted automatically on March 13, 2019 pursuant to the Issuer's Director Compensation Policy upon such Reporting Person's election to the Board of Directors of the Issuer in connection with the closing of the Merger."}],"balance_after":6854,"derivative":{"exercise_price":18.66,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":6854},"source":{"system":"sec-edgar","filing":"0000899243-19-009670","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/905536/000089924319009670/doc4a.xml","form_type":"4/A","original_submission_date":"2019-03-14"}},{"id":3570216,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-02T20:02:00.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":70796,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the Reporting Person's stock option to acquire 744,967 shares of X4 common stock for $0.65 per share that was assumed by the Issuer in the merger of Artemis AC Corp., a wholly-owned subsidiary of the Issuer, with and into X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) (\"X4\") on March 13, 2019 (the \"Merger\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":70796,"derivative":{"exercise_price":6.84,"expiration_date":"2025-12-14","underlying":"Common Stock","underlying_shares":70796},"source":{"system":"sec-edgar","filing":"0000899243-19-009670","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000089924319009670/doc4a.xml","form_type":"4/A","original_submission_date":"2019-03-14"}},{"id":3591530,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-03-18T17:42:10.000Z","date":"2019-03-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of RSUs granted to the Reporting Person on August 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-19-011917","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/905536/000112760219011917/form4.xml","form_type":"4"}},{"id":3591529,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-18T17:42:10.000Z","date":"2019-03-15","kind":"exercise","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of RSUs granted to the Reporting Person on August 14, 2018."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001127602-19-011917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000112760219011917/form4.xml","form_type":"4"}},{"id":3591527,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-03-18T17:38:53.000Z","date":"2019-03-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of RSUs granted to the Reporting Person on August 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-19-011911","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/905536/000112760219011911/form4.xml","form_type":"4"}},{"id":3591526,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-18T17:38:53.000Z","date":"2019-03-15","kind":"exercise","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of RSUs granted to the Reporting Person on August 14, 2018."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001127602-19-011911","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000112760219011911/form4.xml","form_type":"4"}},{"id":3596159,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-03-14T21:35:16.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":70796,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the Reporting Person's stock option to acquire 744,967 shares of X4 common stock for $0.65 per share that was assumed by the Issuer in the merger of Artemis AC Corp., a wholly-owned subsidiary of the Issuer, with and into X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) (\"X4\") on March 13, 2019 (the \"Merger\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":70796,"derivative":{"exercise_price":6.84,"expiration_date":"2025-12-14","underlying":"Common Stock","underlying_shares":70796},"source":{"system":"sec-edgar","filing":"0000899243-19-007828","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000089924319007828/doc4.xml","form_type":"4"}},{"id":3714883,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-02T16:23:20.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":8519,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8519,"derivative":{"exercise_price":3.23,"exercise_date":"2018-12-31","expiration_date":"2028-12-30","underlying":"Common Stock","underlying_shares":8519},"source":{"system":"sec-edgar","filing":"0001578563-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000157856319000001/primary_doc.xml","form_type":"4"}},{"id":3804765,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-01T14:09:50.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":6041,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6041,"derivative":{"exercise_price":4.67,"exercise_date":"2018-09-28","expiration_date":"2028-09-28","underlying":"Common Stock","underlying_shares":6041},"source":{"system":"sec-edgar","filing":"0001562180-18-004059","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000156218018004059/primarydocument.xml","form_type":"4"}},{"id":3843895,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2018-08-15T08:01:29.000Z","date":"2018-08-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-18-025372","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000112760218025372/form4.xml","form_type":"4"}},{"id":3879471,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-07-02T17:24:08.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":6881,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6881,"derivative":{"exercise_price":4.34,"exercise_date":"2018-06-29","expiration_date":"2028-06-29","underlying":"Common Stock","underlying_shares":6881},"source":{"system":"sec-edgar","filing":"0001562180-18-003165","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000156218018003165/primarydocument.xml","form_type":"4"}},{"id":3886481,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true}}],"security":"Stock Option (Right To Purchase)","published_at":"2018-06-21T09:22:53.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These options expire on the third anniversary of the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":1.1,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001127602-18-021660","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000112760218021660/form4.xml","form_type":"4"}},{"id":3929243,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-17T19:18:52.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":8357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in full on May 15, 2019, subject to the grantee's continued service on such vesting date."}],"balance_after":8357,"derivative":{"exercise_price":3.71,"exercise_date":"2019-05-15","expiration_date":"2028-05-14","underlying":"Common Stock","underlying_shares":8357},"source":{"system":"sec-edgar","filing":"0001578563-18-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000157856318000007/primary_doc.xml","form_type":"4"}},{"id":3961611,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2018-04-18T21:40:38.000Z","date":"2018-04-16","kind":"exercise","acquired":false,"price":0,"reported_value":500000,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to its terms, the unpaid principal balance of the convertible promissory note in the principal amount of $500,000 that the issuer issued to a trust affiliated with the reporting person in November 2017, plus accrued and unpaid interest thereon, converted into 103.7 shares of Series E Preferred Stock and warrants to purchase 777,750 shares of common stock upon the closing of the Offering. As a result of such conversion, the note has been satisfied in full and is no longer outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"N/A"},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F7","text":"The note converted into 103.7 shares of Series E Convertible Preferred Stock and warrants to purchase 777,750 shares of common stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"The note converted into 103.7 shares of Series E Convertible Preferred Stock and warrants to purchase 777,750 shares of common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The applicable securities are held by River Charitable Remainder Unit Trust, FBO Isaac Blech, July 20, 1987, Isaac Blech Trustee, of which trust the reporting person is sole trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of these securities for purposes of Section 16 of the Securities Exchange Act of 1934 as amended, or for any other purpose."}],"derivative":{"exercise_price":5000,"exercise_date":"2018-04-16","underlying":"Preferred Stock/Warrants"},"source":{"system":"sec-edgar","filing":"0001493152-18-005442","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315218005442/form4.xml","form_type":"4"}},{"id":3961610,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2018-04-18T21:40:38.000Z","date":"2018-04-16","kind":"exercise","acquired":true,"shares":777750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to its terms, the unpaid principal balance of the convertible promissory note in the principal amount of $500,000 that the issuer issued to a trust affiliated with the reporting person in November 2017, plus accrued and unpaid interest thereon, converted into 103.7 shares of Series E Preferred Stock and warrants to purchase 777,750 shares of common stock upon the closing of the Offering. As a result of such conversion, the note has been satisfied in full and is no longer outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrants expire on the five year anniversary of the closing of the Offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The applicable securities are held by River Charitable Remainder Unit Trust, FBO Isaac Blech, July 20, 1987, Isaac Blech Trustee, of which trust the reporting person is sole trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of these securities for purposes of Section 16 of the Securities Exchange Act of 1934 as amended, or for any other purpose."}],"balance_after":777750,"derivative":{"exercise_price":0.55,"exercise_date":"2018-04-16","underlying":"common stock","underlying_shares":777750},"source":{"system":"sec-edgar","filing":"0001493152-18-005442","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315218005442/form4.xml","form_type":"4"}},{"id":3961609,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2018-04-18T21:40:38.000Z","date":"2018-04-16","kind":"exercise","acquired":true,"shares":103.7,"price":5000,"value":518500.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to its terms, the unpaid principal balance of the convertible promissory note in the principal amount of $500,000 that the issuer issued to a trust affiliated with the reporting person in November 2017, plus accrued and unpaid interest thereon, converted into 103.7 shares of Series E Preferred Stock and warrants to purchase 777,750 shares of common stock upon the closing of the Offering. As a result of such conversion, the note has been satisfied in full and is no longer outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each outstanding share of Series E Preferred Stock shall be converted into common stock on the earliest to occur of: (i) any date more than 30 trading days after the closing of the Offering that the closing price of common stock on each of the 30 days immediately prior to such conversion exceeds $5.00; (ii) the three year anniversary of the closing of the Offering; and (iii) the date on which the holders of a majority of the outstanding shares of Series E Preferred Stock elect to convert all of the outstanding shares of Series E Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The applicable securities are held by River Charitable Remainder Unit Trust, FBO Isaac Blech, July 20, 1987, Isaac Blech Trustee, of which trust the reporting person is sole trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of these securities for purposes of Section 16 of the Securities Exchange Act of 1934 as amended, or for any other purpose."}],"balance_after":103.7,"derivative":{"exercise_price":0.5,"exercise_date":"2018-04-16","underlying":"common stock","underlying_shares":1037000},"source":{"system":"sec-edgar","filing":"0001493152-18-005442","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315218005442/form4.xml","form_type":"4"}},{"id":3961608,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2018-04-18T21:40:38.000Z","date":"2018-04-16","kind":"grant","acquired":true,"shares":16875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the closing of the issuer's private placement of shares of its Series E Convertible Preferred Stock and warrants to purchase shares of its common stock (the \"Offering\"), which occurred on April 16, 2018, the issuer and the reporting person agreed that the issuer would satisfy all accrued and unpaid fees owed by the issuer to the reporting person for services as a member of the issuer's Board of Directors prior to January 1, 2018, by the issuance by the issuer to the reporting person of 2.25 shares of Series E Preferred Stock and warrants to purchase 16,875 shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrants expire on the five year anniversary of the closing of the Offering."}],"balance_after":16875,"derivative":{"exercise_price":0.55,"exercise_date":"2018-04-16","underlying":"common stock","underlying_shares":16875},"source":{"system":"sec-edgar","filing":"0001493152-18-005442","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315218005442/form4.xml","form_type":"4"}},{"id":3961607,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2018-04-18T21:40:38.000Z","date":"2018-04-16","kind":"grant","acquired":true,"shares":2.25,"price":5000,"value":11250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the closing of the issuer's private placement of shares of its Series E Convertible Preferred Stock and warrants to purchase shares of its common stock (the \"Offering\"), which occurred on April 16, 2018, the issuer and the reporting person agreed that the issuer would satisfy all accrued and unpaid fees owed by the issuer to the reporting person for services as a member of the issuer's Board of Directors prior to January 1, 2018, by the issuance by the issuer to the reporting person of 2.25 shares of Series E Preferred Stock and warrants to purchase 16,875 shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each outstanding share of Series E Preferred Stock shall be converted into common stock on the earliest to occur of: (i) any date more than 30 trading days after the closing of the Offering that the closing price of common stock on each of the 30 days immediately prior to such conversion exceeds $5.00; (ii) the three year anniversary of the closing of the Offering; and (iii) the date on which the holders of a majority of the outstanding shares of Series E Preferred Stock elect to convert all of the outstanding shares of Series E Preferred Stock."}],"balance_after":2.25,"derivative":{"exercise_price":0.5,"exercise_date":"2018-04-16","underlying":"common stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001493152-18-005442","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315218005442/form4.xml","form_type":"4"}},{"id":3970743,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-04T14:33:24.000Z","date":"2018-03-31","kind":"grant","acquired":true,"shares":6111,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6111,"derivative":{"exercise_price":4.29,"exercise_date":"2018-03-31","expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":6111},"source":{"system":"sec-edgar","filing":"0001562180-18-001827","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000156218018001827/primarydocument.xml","form_type":"4"}},{"id":4106025,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-05T09:17:38.000Z","date":"2017-12-31","kind":"grant","acquired":true,"shares":8267,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8267,"derivative":{"exercise_price":3.2,"exercise_date":"2017-12-31","expiration_date":"2027-12-30","underlying":"Common Stock","underlying_shares":8267},"source":{"system":"sec-edgar","filing":"0001104659-18-000890","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000110465918000890/a4.xml","form_type":"4"}},{"id":4115591,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-01-03T19:01:06.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 1,900 shares of common stock are exercisable beginning on January 3, 2018, and options to purchase 1,900 shares of common stock are exercisable beginning on January 3, 2019."}],"balance_after":3800,"derivative":{"exercise_price":1.56,"expiration_date":"2023-01-03","underlying":"common stock","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0001587074-18-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000158707418000005/primary_doc.xml","form_type":"4"}},{"id":4151389,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-27T17:17:08.000Z","date":"2017-11-22","kind":"grant","acquired":true,"shares":473457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Security granted on November 22, 2017 under the Issuer's 2014 Long-Term Incentive Plan as an initial one-time grant to the Reporting Person in connection with his appointment to the Issuer's Board of Directors on November 22, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in twenty (20) equal (or as nearly equal as possible) quarterly installments beginning December 31, 2017."}],"balance_after":473457,"derivative":{"exercise_price":1.8,"expiration_date":"2017-11-22","underlying":"Common Stock","underlying_shares":473457},"source":{"system":"sec-edgar","filing":"0000905536-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000090553617000002/primary_doc.xml","form_type":"4"}},{"id":4192753,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-10-04T14:23:14.000Z","date":"2017-09-30","kind":"grant","acquired":true,"shares":27560,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27560,"derivative":{"exercise_price":0.85,"exercise_date":"2017-09-30","expiration_date":"2027-09-29","underlying":"Common Stock","underlying_shares":27560},"source":{"system":"sec-edgar","filing":"0001562180-17-003188","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000156218017003188/primarydocument.xml","form_type":"4"}},{"id":4248812,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-07-31T13:35:36.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":8357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in full on June 30, 2018, subject to the grantees continued service on such vesting date."}],"balance_after":8357,"derivative":{"exercise_price":0.57,"exercise_date":"2018-06-30","expiration_date":"2027-06-29","underlying":"Common Stock","underlying_shares":8357},"source":{"system":"sec-edgar","filing":"0001562180-17-002531","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000156218017002531/primarydocument.xml","form_type":"4"}},{"id":4250427,"issuer":{"id":116797,"kind":"organization","name":"CONTRAFECT Corp","symbol":"CFRX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2017-07-27T16:29:26.000Z","date":"2017-07-25","kind":"purchase","acquired":true,"shares":8000,"price":0.01,"value":80.0,"ownership":{"direct":true},"balance_after":8000,"derivative":{"exercise_price":1.55,"exercise_date":"2017-07-25","expiration_date":"2022-07-25","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-17-046446","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/905536/000120919117046446/doc4.xml","form_type":"4"}},{"id":4250426,"issuer":{"id":116797,"kind":"organization","name":"CONTRAFECT Corp","symbol":"CFRX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-07-27T16:29:26.000Z","date":"2017-07-25","kind":"purchase","acquired":true,"shares":16000,"price":1.24,"value":19840.0,"ownership":{"direct":true},"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001209191-17-046446","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000120919117046446/doc4.xml","form_type":"4"}},{"id":4265844,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-07-05T13:39:43.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":36982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vested immediately and became exercisable in full upon grant on 6/30/2017."}],"balance_after":36982,"derivative":{"exercise_price":0.57,"exercise_date":"2017-06-30","expiration_date":"2027-06-29","underlying":"Common Stock","underlying_shares":36982},"source":{"system":"sec-edgar","filing":"0001562180-17-002385","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000156218017002385/primarydocument.xml","form_type":"4"}},{"id":4275631,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true}}],"security":"Stock Option (right To Purchase)","published_at":"2017-06-21T14:28:39.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":15000,"price":10.15,"value":152250.0,"ownership":{"direct":true},"balance_after":15000,"derivative":{"exercise_price":10.15,"exercise_date":"2018-06-20","expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001127602-17-021957","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000112760217021957/form4.xml","form_type":"4"}},{"id":4363032,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-04T14:05:43.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":26342,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26342,"derivative":{"exercise_price":0.68,"exercise_date":"2017-03-31","expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":26342},"source":{"system":"sec-edgar","filing":"0001562180-17-001403","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000156218017001403/primarydocument.xml","form_type":"4"}},{"id":4504751,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-01-04T14:54:34.000Z","date":"2016-12-31","kind":"grant","acquired":true,"shares":17827,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options immediately vested and became exercisable in full upon grant on December 31, 2016."}],"balance_after":17827,"derivative":{"exercise_price":0.88,"exercise_date":"2016-12-31","expiration_date":"2026-12-30","underlying":"Common Stock","underlying_shares":17827},"source":{"system":"sec-edgar","filing":"0001562180-17-000140","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000156218017000140/primarydocument.xml","form_type":"4"}},{"id":4521100,"issuer":{"id":7318,"kind":"organization","name":"InspireMD, Inc.","symbol":"NSPR"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase Common Stock","published_at":"2016-12-15T06:03:23.000Z","date":"2016-12-07","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in three equal annual installments, with 1/3 becoming exercisable on each of December 7, 2017, December 7, 2018 and December 7, 2019, subject to Mr. Blech's continued service."}],"balance_after":12500,"derivative":{"exercise_price":3.04,"expiration_date":"2026-12-07","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-16-015887","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000149315216015887/form4.xml","form_type":"4"}},{"id":4590848,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-10-03T15:10:51.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":3723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options immediately vested and became exercisable in full upon grant on September 30, 2016."}],"balance_after":3723,"derivative":{"exercise_price":4.23,"expiration_date":"2026-09-29","underlying":"Common Stock","underlying_shares":3723},"source":{"system":"sec-edgar","filing":"0001179110-16-030160","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000117911016030160/edgar.xml","form_type":"4"}},{"id":4601984,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":157145,"kind":"person","name":"BLECH ISAAC","position":1,"cik":"0000905536","reported_name":"BLECH ISAAC","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-16T16:05:21.000Z","date":"2016-08-31","kind":"grant","acquired":true,"shares":204907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Security granted on August 31, 2016 under the Issuer's 2015 Equity Incentive Plan, as amended, as an initial one-time grant to the Reporting Person in connection with his appointment to the Issuer's Board of Directors on August 11, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in 40 quarterly equal (or as nearly equal as possible) installments beginning September 30, 2016."}],"balance_after":204907,"derivative":{"exercise_price":8,"expiration_date":"2026-08-31","underlying":"Common Stock","underlying_shares":204907},"source":{"system":"sec-edgar","filing":"0001437749-16-038810","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905536/000143774916038810/rdgdoc.xml","form_type":"4"}}]}